Sol-Gel reported a net loss of $0.4 million for the third quarter of 2024 and loss of $0.01 per basic and diluted share, compared to a net loss of $5.7 million and a loss of $0.21 per basic and ...
(NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its financial results for ...
About PYRUKYND® (mitapivat) PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the United States, and for the ...
It can also aid in altering your relationship with food and eating, and developing a recovery and relapse plan. Occupational therapy (OT) is increasingly becoming a part of eating disorder treatment ...
An Aberdeen councillor who described an opponent as a "New Scot" breached the code of conduct, it has been ruled. The SNP's Kairin van Sweeden made the remark against Labour's Deena Tissera during ...
Your dementia treatment plan will depend on underlying causes and how advanced your condition is. Not everyone needs significant lifestyle changes or medication, particularly in early stage dement ...
Honesty, integrity and competence, as well as concern for others and for the environment, are the foundations of the RIBA's three principles of professional conduct. Complaints are handled in line ...